| Literature DB >> 29777471 |
Isabel Yorke1, Pippa White2, Amelia Weston3, Monica Rafla2, Tony Charman2, Emily Simonoff2.
Abstract
This review (Prospero Registration Number: CRD42017057915) aimed to systematically identify and summarize existing research on the relationship between additional emotional and behavioral problems (EBP) in children with autism, and parenting stress (PS) and mental health problems (MHP) in their parents. Sixty-seven studies met criteria for inclusion in the review, 61 of which were included in the meta-analysis. Pooled correlation coefficients were in the low to moderate range ([Formula: see text]). Some evidence for moderation by measurement characteristics was found. Narrative review of concurrent adjusted associations showed some evidence for shared relationships with other factors, most notably ASD severity and parent perception of own parenting. Longitudinal studies showed mixed evidence for bidirectional predictive relationships between child EBP and parent psychological distress variables.Entities:
Keywords: Additional psychopathology; Autism spectrum disorder; Emotional and behavioral problems; Mental health; Parenting stress; Psychological distress
Mesh:
Year: 2018 PMID: 29777471 PMCID: PMC6153902 DOI: 10.1007/s10803-018-3605-y
Source DB: PubMed Journal: J Autism Dev Disord ISSN: 0162-3257
Study characteristics
| Study | Sample size; recruitment source | Child: proportion male | Child: proportion with ASD; source | Child: mean age (SD), range | Parent: proportion mothers | Parent: mean age (SD), range | Child measure (subscale) | Parent measure (subscale) | Effect size (N in analysis) | Meta-analysis number |
|---|---|---|---|---|---|---|---|---|---|---|
| Bader and Barry ( | 84; community | .87 | 1.00; parent | 11.0 (3.3), 6-16a | .96 | 43.0 (6.4), 30–56 | CBCL 6–18 (ext.) | PSI-SF (PD) | – | – |
| Bader et al. ( | 111; community | .86 | 1.00; parent | 11.0 (3.5), 6–18 | .97 | 42.0 (6.8), 25–58 | CBCL 6–18 (ext.) | PSI-SF (PD) | .27 (111) | 1, 2, 8 |
| Baker et al. ( | 149; community | .74 | 1.00; research | 14.8 (1.9), 10–22 | 1.00 | 44.4 (5.2), NR | SIB-R GMI | CES-D | .28 (137a) | 4 |
| Beer et al. ( | 28; clinic | .86 | 1.00; clinical | 9.0 (4.3), 3–20 | .86 | 43.2 (8.4), 32–76 | NCBRF | QRS-F (PFP-5D) | .81 (28) | 1, 8 |
| Bekhet ( | 117; community | .86 | 1.00; parent | 10.9 (3.3), 3–17 | .97 | 41.0 (6.0), 23–58 | NCBRF | CES-D | .35d (117) | 4 |
| Benson ( | 113; community | .86 | 1.00; research | 8.6 (1.5), NR | 1.00 | 42.0 (5.2), NR | NCBRF | Own MHP scale | – | – |
| Benson and Kersh ( | 96; community | .87 | 1.00; research | 8.7 (1.5), NR | 1.00 | 41.9 (5.0), NR | NCBRF | CES-D | .32 (96) | 4 |
| Brobst et al. ( | 25; community | NR | 1.00; parent | 6.6 (2.7), 2–12 | 1.00 | 38.5 (6.5), 23–55 | ECBI (intensity) | PSI-SF | .54 (23) | 1 |
| Bromley et al. ( | 71; community | .80 | 1.00; parent | 10.3a (NR), ≤ 18 | 1.00 | NR | DBC-P | GHQ-12 | .30b (68c) | 4 |
| Chu and Richdale ( | 46; community | NR | .56; parent | 7.2 (2.4), 2–12 | 1.00 | 40.2 (6.2), 28–57 | SDQ | PHS (freq.) | .50 (43) | 1 |
| Conner et al. ( | 30; community | NR | 1.00; research | NR (NR), 12–17 | .97 | NR | ABC (irrit.) | STAI-state | .70 (30) | 4, 5 |
| Conner and White ( | 67; community | .82 | 1.00; parent | 10.5a (NR), 4–17 | 1.00 | 41.0 (7.2), 27–57 | ABC (irrit.) | Perc. SS | .37 (67)e | 1, 2, 8 |
| Craig et al. ( | 45; clinic | .66 | 1.00; clinical | 8.3 (3.6), 3–12 | 1.00 | 41.8 (4.8), NR | CBCL 1.5-5/6–18 | PSI-SF | .21b (42) | 1 |
| Falk et al. ( | 250; community | NR | 1.00; parent | 8.4 (3.9), 4–17 | 1.00 | 39.9 (6.3), 24–58 | SDQ (cond.) | DASS-21 (stress) | .31 (250) | 1, 2, 8 |
| Farmer et al. ( | 124; clinic | .85 | 1.00; research | 7.4 (2.4), 4–14 | NR | NR | ABC (irrit.) | PSI-SF | .39e (124) | 1, 2 |
| Firth and Dryer ( | 109; community | .80 | 1.00; parent | 7.9 (2.4), 4–12 | NR | NR | NCBRF | PSS | .30 (109) | 1, 8 |
| Fitzgerald et al. ( | 100; population | .76 | 1.00; parent | 13.6 (NR), 2–25 | 1.00 | 45.0 (NR), 27–67 | VABS-MBD (Part 1) | GHQ-30 | .29 (100) | 4 |
| Foody et al. ( | 74; NR | .77 | 1.00; clinical | 8.9 (3.6), 2–17 | 1.00 | 41.2 (6.0), 26–65 | CPRS (oppos.) | PSI-SF | .60 (51)e | 1, 2 |
| Fung et al. ( | 91; community | .82 | 1.00; parent | 13.4 (5.1), 7–25 | .90 | 44.3 (7.3), 31–62 | GDS-CS | K6 | .43 (91) | 4 |
| Gallagher et al. ( | 32; community | NR | .66; parent | 11.5 (3.4), 3–19 | .75 | 42.8 (5.8), NR | SDQ | HADS (anx.) | .17d,e (32) | 4 |
| Giovagnoli et al. ( | 130; clinic | .85 | 1.00; research | 3.5 (.8), NR | NR | 37.7 (2.2), NR | CBCL 1.5-5 | PSI-SF | .28 (130)e | 1 |
| Hall and Graff ( | 70; community | .83 | 1.00; parent | 8.7 (4.2), 3–21 | .69 | 40.0 (8.5), NR | MBI | PSI-SF | .46 (70) | 1 |
| Hastings and Brown ( | 26; community | .65 | 1.00; clinical | 12.2 (2.5), NR | 1.00 | 41.0 (5.0), NR | DBC-T | HADS (anx.) | .54d (26) | 7 |
| Hastings et al. ( | 48; clinic | .85 | 1.00; research | 3.1 (.37), 2.3–3.8 | 1.00 | 34.5 (4.1), NR | DBC-P (mother) | QRS-F (PFP-5D) | .59 (48) | 1 |
| Hastings et al. ( | 60; community | .80 | 1.00; parent | 9.8 (2.3), 4–15 | 1.00 | 42.1 (4.8), 28–52 | SDQ | HADS (dep.) | .24 (60)e | 4 |
| Herring et al. ( | 79; clinic | .89 | 1.00; research | 3.1 (.6), 1–4 | 1.00 | NR | DBC-P | GHQ-28 | .37 (78)e | 4 |
| Huang et al. ( | 52; clinic | .94 | 1.00; clinical | 6.3 (2.3), 3–12 | .87 | 39.2 (5.9), NR | Chinese SDQ | Chinese PSI-SF | .43 (52)e | 1 |
| Jellett et al. ( | 97; community | .85 | 1.00; parent | 4.3 (1.1), 1–5 | .91 | 36.1 (5.5), NR | DBC-P24 | DASS-21 (stress) | .39 (97) | 1, 8 |
| Jones et al. ( | 71; community | .83 | 1.00; parent | 13.0 (2.3), 7–16 | 1.00 | 45.0 (4.6), NR | SDQ | HADS (anx.) | .29d (70) | 4 |
| Kerns et al. ( | 59; community | .78 | 1.00; research | 10.6 (2.8), 7–17 | NR | NR | BASC-2 (dep.) | PSI/SIPA (child age dependent) | .66 (48) | 1, 3 |
| Kim et al. ( | 234; community | .82 | 1.00; parent | 7.1 (3.4), 2–19 | 1.00 | 37.5 (7.1), NR | Own EBP scale | CES-D BSF | .35 (234) | 4 |
| Krakovich et al. ( | 79; community | NR | 1.00; research | 5.9 (1.6), 3–9 | .91 | NR | BASC-2 BSI | PSI (Parent Domain) | .42 (75) | 1, 8 |
| Lancaster et al. ( | 27; community | .82 | .55; parent | 7.0 (2.1), 4–9 | 1.00 | 35.0 (5.7), 25–44 | BPI-01 (frequency) | HADS (dep.) | .55e (27) | 4 |
| Lecavalier et al. ( | 293; community | .83 | 1.00; parent | 9.0 (3.4), 3–18 | .86 | 39.9 (7.1), NR | NCBRF (cond.) | PSI-SF | .40b (253) | 1, 2 |
| Lee and Chiang ( | 138; community | .75 | 1.00; clinical | 15.8 (1.9), 10–19 | 1.00 | 45.1 (3.9), NR | Korean VABS-2 MBI (dichotomized) | Korean SIPA | .46h (138) | 1 |
| Lovell and Wetherell ( | 118; community | NR | 1.00; parent | 9.8 (4.4), 3–19 | .94 | 41.3 (7.6), 23–63 | SDQ | Perc. SS | .28 (118) | 1 |
| Machado et al. ( | 102; community | .84 | 1.00; clinical | 10.3 (5.3), 3–21 | .82 | 40.6a (6.6a), 26–62 | ABC | HADS | .26g (102) | 4 |
| Manning et al. ( | 195; community | .83 | 1.00; parent | 8.8 (2.1), 6–12 | .96 | 40.9 (6.1), 24–54 | CBCL | PSI-SF (PD) | .39 (195) | 1, 8 |
| McStay et al. ( | 150; community | .87 | 1.00; clinical | 13.2 (3.0), 6.−18 | .72 | NR | DBD (cond.) | Dutch PSI-SF (PD) | .19 (150) | 1, 2, 8 |
| McStay et al. ( | 98; community | .86 | 1.00; parent | 8.9 (3.8), 3–16 | 1.00 | 41.8 (6.0), NR | BASC-2 (ext.) | PSI-SF (PD) | .36 (98) | 1, 2, 8 |
| Osborne and Reed ( | 65; community | .91 | 1.00; clinical | 3.3 (.8), 2–4 | NR | NR | CPRS | QRS-F | – | – |
| Osborne and Reed ( | 72; community | .97 | 1.00; clinical | 8.7 (3.5), 5–16 | NR | NR | SDQ | PSI | – | – |
| Pakenham et al. ( | 47; community | .85 | 1.00; parent | 10.8 (NR), 10–12 | 1.00 | NR | ECBI (intensity) | DASS-21 (anx.) | .31 (47) | 4 |
| Park et al. ( | 56; clinic | .86 | 1.00; clinical | 9.4 (2.0), 6–13 | 1.00 | NR | Korean CBCL | STAI-S | .47 (56) | 4 |
| Paynter et al. ( | 43; community | .84 | 1.00; parent | 4.1 (.8), 2–6 | .58 | 37.4 (7.9), NR | SDQ | PSI-SF | .65 (41) | 1 |
| Peters-Scheffer et al. ( | 104; community | .75 | 1.00; research | 5.5a (NR), 2–9 | 1.00 | NR | CBCL 1.5-5 | Dutch PSI-SF | .55 (102) | 1 |
| Reaven et al. ( | 31; clinical | .74 | 1.00; research | 13.8 (3.0), 7–18 | .84 | 44.4 (7.4), 30–75 | SCARED-P | STAI-state | .21 (31) | 4, 6 |
| 32; community | NR | 1.00; clinical | 3.5 (.6), > 5 | 1.00 | NR | DBC-P | QRS-F | – | – | |
| Reed et al. ( | 93; community | .83 | 1.00; parent | 10.5 (4.1), 3–18 | 1.00 | 43.3 (6.8), 25–58 | SDQ | QRS-F | .28 (93) | 1 |
| Rezendes and Scarpa ( | 134; community | .80 | 1.00; parent | 9.2 (NR), 3–16 | 1.00 | 39.0 (8.0), NR | SDQ | QRS-F | .27 (133) | 1 |
| Robinson and Neece ( | 44; community | .71 | .89; parent | 3.4 (1.0), 2–5 | .77 | 35.2 (8.5), NR | CBCL 1.5-5 | PSI-SF (PD) | .51 (44) | 1, 8 |
| Salazar et al. ( | 101; population | .82 | 1.00; research | 6.7 (1.2), 4–9 | .94 | NR | DBC-P | K10 | .25 (86)e | 4 |
| Sawyer et al. ( | 216; community | .88 | 1.00; clinical | 11.0 (2.9), 6–17 | 1.00 | NR | SDQ | GHQ-30 | .23 (216) | 4 |
| Shawler and Sullivan ( | 130; community | .89 | 1.00; clinical | 8.6 (2.4), 3–11 | .92 | 39.8 (6.6), 24–58 | ECBI (intensity) | PSI-SF | .72 (128) | 1 |
| Simonoff et al. ( | 158; population | .90 | 1.00; research | 11.7 (.9), 10–13 | NR | NR | SDQ-P | PSI-SF | .33 (127) | 1 |
| GHQ-12 | .14 (125) | 4 | ||||||||
| SDQ-T | .01 (108) | 7 | ||||||||
| SDQ-P | PSI-SF (PD) | .19 (127) | 8 | |||||||
| Skokauskas and Gallagher ( | 67; community | .88 | 1.00; research | 12.7 (2.9), NR | NR | 48.9 (6.2), NR | CBCL 6–18 | BSI-GSI | .13 (67) | 4, 5 |
| Stoppelbein et al. ( | 45; clinic | .80 | 1.00; research | 8.7 (2.2), 6–12 | .84 | NR | CBCL 6–18 (ext.) | HSCL | .37 (45) | 4, 5 |
| Suzuki et al. ( | 405; clinic | NR | .69; clinical | 10.2 (3.5), 3–18 | 1.00 | 41.6 (5.4), 28–54 | Japanese SDQ | Japanese GHQ-12 | .22 (313) | 4 |
| Taylor and Warren ( | 75; clinic | .88 | 1.00; research | 5.1a (NR), NR | 1.00 | NR | CBCL | CES-D | .45 (75) | 4 |
| Totsika et al. ( | 132; population | .82 | 1.00; parent | 3.5a (NR), 3–3 | 1.00 | 31.5a (NR), NR | SDQ | K6 | .14 (132) | 4 |
| Valicenti-McDermott et al. ( | 50; clinical | .94 | 1.00; clinical | 8.8 (3.0), 2–18 | 1.00 | 38.0 (7.0), NR | ABC | PSI-SF | .32 (50)i | 1 |
| Walsh et al. ( | 132; community | .77 | 1.00; parent | 9.3 (4.9), 2–18 | 1.00 | NR | ABC | PDH (intensity) | .62 (132) | 1 |
| Warfield et al. ( | 74; clinic | .82 | 1.00; clinical | 6.8 (1.2), 4–9 | NR | NR | Observational assessment (ext.) | PSI-SF (PD) | – | – |
| Weiss et al. ( | 228; community | .82 | 1.00; parent | 11.8 (3.6), 6–21 | .93 | NR | NCBRF | K6 | .39 (228) | 4 |
| Weiss et al. ( | 101; community | .75 | 1.00; parent | 14.5 (2.1), 12–21 | 1.00 | NR | NCBRF (insec/anx.) | PSS | .41 (101) | 1, 3, 8 |
| Weitlauf et al. ( | 70; clinic | .88 | 1.00; clinical | 5.0 (NR), NR | 1.00 | NR | CBCL | PSI-SF | .54 (70) | 1 |
| Zaidman-Zait et al. ( | 184; clinic | .84 | 1.00; research | 3.0 (.6), 2–3 | 1.00 | NR | CBCL 1.5-5 | PSI-SF (PD) | – | – |
| Zaidman-Zait et al. ( | 283; clinic | .84 | 1.00; research | 3.2 (.7), 2–4 | 1.00 | 35.4 (5.4), 20–48 | CBCL 1.5-5 (ext.) | PSI-SF (PD & GD composite) | .36 (283) | 1, 2, 8 |
The meta-analysis numbers correspond to the analyses (presented in Table 2) in which each effect size was included
NR not reported, “–” no effect size eligible for meta-analysis (study included in narrative syntheses only). Measures are full-scale composites unless a subscale is specified
Child measures: ABC Aberrant Behavior Checklist, BASC2 Behavior Assessment System for Children (Second Edition), BPI-01 Behavior Problems Inventory CASI-20-P[O] 20-item Childhood Anxiety Sensitivity Index-Parent[Observer] version, CBCL 1.5-5[6–18] Child Behavior Checklist (for 1.5-5[6–18] year olds), CPRS Conners’ Parent Rating Scale, DBC-P[T] Developmental Behavior Checklist-Parent[Teacher] version, DBC-P24 24-item DBC-P, DBD Disruptive Behavior Disorders rating scale, ECBI Eyberg Child Behavior Inventory, GDS-CS Glasgow Depression Scale-Carer Supplement, MBI Maladaptive Behavior Index, NCBRF Nisonger Child Behavior Rating Form, SDQ Strengths and Difficulties Questionnaire, SIB-R GMI Scales of Independent Behavior-Revised General Maladaptive Index, VABS-MBD Vineland Adaptive Behavior Scales-Maladaptive Behavior Domain
Child subscales: cond conduct problems subscale, disrupt disruptive behavior subscale, emot emotional symptoms subscale ext externalizing subscale, insec/anx insecure/anxious subscale, int internalizing subscale, irrit irritability subscale, oppos oppositional Behavior subscale
Parenting stress measures: PHS Parenting Hassles Scale, Perc SS Perceived Stress Scale, PSI-SF Parenting Stress Index-Short Form, PSS Parenting Stress Scale, QRS-F Questionnaire on Resources and Stress-Friedrich Shortform
Parenting stress subscales: PD Parental Distress, PFP Parent and Family Problems, PFP-5D Parent and Family Problems-minus five depression items
Subscales: anx anxiety, dep depression
Parent MHP measures: CES-D Center for Epidemiologic Studies Depression Scale, CES-D BSF CES-D Boston Short Form, DASS-21 21-item Depression, Anxiety and Stress Scale, GHQ-12[28] 12[28]-item General Health Questionnaire,; HADS Hospital Anxiety and Depression Scale, STAI State-Trait Anxiety Inventory
aEstimate based on information given in the paper
bConverted from Spearman’s rho value
cAssumed that parents contributed one data-point each
dUnadjusted standardized regression coefficient (beta)
eData sent by author
fStudies reporting on the same sample
gConverted from phi coefficient
hConverted from t-test
iConverted from Chi square
Pooled effect sizes
| Parenting stress | Parent mental health problems | Parenting stress—refined measure criteria | |
|---|---|---|---|
| Total difficulties | |||
| Meta-analysis number | 1 | 4 | 8 |
| Pooled | .43*** (.38–.48) | .30*** (.26–.34) | .34*** (.28–.39) |
| | 35 | 35 | 22 |
| | 3625 | 3458 | 2430 |
| | 106.81*** | 51.38* | 48.7*** |
| | 69.77% | 30.64% | 54.81% |
| Egger’s regression test ( | 1.72† | 2.81** | |
| Trim and fill | 3 | 0 | |
| Pooled | .30*** (.25–.33) | N/A | |
| Fail-safe | 2206 | ||
| Externalizing | |||
| Meta-analysis number | 2 | 5 | |
| Pooled | .36*** (.31–.40) | .29*** (.17–.40) | |
| | 17 | 11 | |
| | 2024 | 919 | |
| | 27.14* | 28.77** | |
| | 33.37% | 68.49% | |
| Internalizing | |||
| Meta-analysis number | 3 | 6 | |
| Pooled | .36*** (.27–.44) | .25*** (.12–.37) | |
| | 13 | 9 | |
| | 1420 | 583 | |
| | 34.53*** | 19.14* | |
| | 67.14% | 59.22% | |
| Total difficulties—alternative rater | |||
| Meta-analysis number | N/Aa | 7 | |
| Pooled | .21* (.04–.37) | ||
| | 6 | ||
| | 11.72* | ||
| | 332 | ||
| | 55.92% | ||
k number of effect sizes included; N total number of individuals
†p < .10; *p < .05; **p < .01; ***p <. 001
aAnalysis not performed due to low number of eligible effect sizes (k = 3)
Fig. 1Search results and screening process
Single time-point analyses of PS-EBP relationship, adjusted for other factors
| Study | N | Analysis | PS | EBP | Child | Parent | Family/context | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | Sex | ASD severity | IQ | Adaptive behavior | Age | Sleep quality | Coping mechanisms | Mindfulness | Perception of own parenting | Family functioning | Social/family support | Income/SES | |||||
| Zaidman-Zait et al. ( | 283 | HMR | DV | ** | – | – | n.s. | – | – | – | – | ** | – | – | *** | *** | n.s. |
| Lecavalier et al. ( | 253 | HMR | DV | * | – | – | C | – | – | – | – | – | – | – | – | – | – |
| Falk et al. ( | 250 | SMR | DV | n.s. | – | – | * | – | – | ** | – | – | – | ** | – | ** | – |
| Manning et al. ( | 195 | HMR | DV | ** | – | – | n.s. | – | – | * | – | *** | – | – | – | n.s. | n.s. |
| McStay et al. ( | 150 | HMR | DV | * | n.s. | – | n.s. | n.s. | – | – | – | – | – | – | – | – | – |
| Rezendes and Scarpa ( | 140 | MR | DV | ** | – | – | C | – | – | C | – | – | – | – | – | – | – |
| Lee and Chiang ( | 138 | SMR | DV | *** | * | * | – | – | – | – | – | – | – | – | – | – | – |
| Giovagnoli et al. ( | 130 | SMR | DV | * | – | – | n.s. | n.s. | n.s. | – | – | – | – | – | – | – | – |
| Bader et al. ( | 111 | HMR | n.s. | DV | n.s. | – | *** | – | – | n.s. | – | – | – | ** | – | – | n.s. |
| Firth and Dryer ( | 109 | HMR | DV | n.s. | n.s. | n.s. | * | – | – | – | – | – | – | – | – | – | – |
| Weiss et al. ( | 101 | HMR | ** | DV | n.s. | n.s. | n.s. | – | – | – | – | – | – | – | – | – | n.s. |
| McStay et al. ( | 98 | HMR | DV | * | n.s. | – | – | – | – | – | – | n.s. | – | – | n.s. | * | – |
| Osborne and Reed ( | 83 | SPC | DV | *** | – | – | C | C | C | – | – | – | – | – | – | – | – |
| Warfield et al. ( | 74 | HMR | DV | n.s. | – | – | – | – | – | – | – | – | – | – | – | ** | – |
| Hall and Graff ( | 70 | MR | DV | *** | – | – | – | – | – | – | – | – | – | – | – | n.s. | – |
| Osborne and Reed ( | 65 | SPC | DV | n.s. | – | – | C | C | C | – | – | – | – | – | – | – | – |
| Jones et al. ( | 61 | HMR | DV | *** | – | – | – | – | – | – | – | – | n.s. | – | – | – | * |
| Huang et al. ( | 52 | MR | DV | n.s. | – | – | n.s. | – | – | – | – | – | – | – | – | – | – |
| Foody et al. ( | 51 | HMR | DV | * | – | – | * | – | n.s. | – | n.s. | – | – | – | – | – | – |
| Kerns et al. ( | 48 | ANC | ** | DV | – | – | C | – | – | – | – | – | – | – | – | – | – |
| Chu and Richdale ( | 46 | SMR | DV | *** | – | – | – | – | – | – | *** | – | – | – | – | – | – |
| Hastings et al. ( | 41 | HMR | DV | *** | – | – | n.s. | – | n.s. | – | – | – | – | – | – | – | – |
| Beer et al. ( | 28 | PC | DV | *** | – | – | – | – | – | – | – | – | C | – | – | – | – |
Studies are presented in order of size (descending). For each study, the dependent variable (DV) is denoted and other variable are treated as independent variables (IV). Their contribution to final model is denoted by its significance (n.s. non-significant; †p < .1; *p < .05; **p < .01; ***p < .001; ****p < .0001). Variables of interest not included as IV in individual studies are denoted with –. Types of analysis are coded as: MR multiple regression (variables entered simultaneously or type not specified); SMR stepwise multiple regression; HMR hierarchical multiple regression; PC partial correlation; SPC semi-partial correlation; LMR logistic multiple regression; C controlled variable
Single time-point analyses of MHP-EBP relationship, adjusted for other factors
| Study | N | Analysis | MHP | EBP | Child | Parent | Family/context | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | Sex | ASD severity | IQ | Age | sleep | Mindfulness/acceptance | PS/burden | Perception of own parenting | Stressful life events | Marital Relationship | Social/Family Support | Income /SES | |||||
| Suzuki et al. ( | 313 | MR | DV | * | – | – | – | – | – | – | – | – | * | – | – | * | – |
| Falk et al. ( | 250 | SMR | DV | n.s. | – | – | *** | – | *** | – | – | – | *** | – | – | – | – |
| Weiss et al. ( | 228 | HMR | DV | ** | n.s. | n.s. | n.s. | – | – | – | *** | – | – | n.s. | – | – | n.s. |
| Sawyer et al. ( | 215 | HMR | DV | * | n.s. | – | – | – | – | – | – | – | – | – | – | ** | – |
| Firth and Dryer ( | 109 | HMR | DV | ** | n.s. | n.s. | n.s. | – | – | – | – | – | – | – | – | – | – |
| Benson and Kersh ( | 96 | HMR | DV | * | – | – | – | – | – | – | – | – | – | * | * | * | n.s. |
| Fung et al. ( | 82 | HMR | *** | DV | * | – | – | † | – | – | – | – | – | n.s. | – | – | * |
| Taylor and Warren ( | 75 | MR | DV | n.s. | – | – | – | – | – | – | – | – | – | – | – | n.s. | * |
| Machado et al. ( | 102 | LMR | DV | ** | – | * | – | – | – | – | – | – | – | – | – | – | – |
| Weitlauf et al. (2012) | 70 | HMR | DV | n.s. | – | – | n.s. | – | – | – | – | *** | – | – | * | – | n.s. |
| Bromley et al. ( | 68 | LMR | DV | * | – | – | – | – | – | – | – | – | – | – | – | * | – |
| Jones et al. ( | 65 | HMR | DV | n.s. | – | – | – | – | – | – | *** | – | – | – | – | – | – |
| Park et al. ( | 56 | HMR | DV | *** | * | – | – | * | – | – | – | – | – | – | – | – | – |
| Pakenham et al. ( | 47 | HMR | DV | n.s. | – | n.s. | – | – | n.s. | – | – | n.s. | – | ** | – | † | n.s. |
| Chu and Richdale ( | 46 | SMR | DV | n.s. | – | – | – | – | – | *** | – | – | – | – | – | – | – |
| Stoppelbein et al. ( | 45 | HMR | n.s. | DV | n.s. | – | – | – | – | – | – | – | – | – | – | – | – |
| Gallagher et al. ( | 32 | SMR | DV | n.s. | – | – | – | – | – | – | – | * | – | – | – | ** | – |
| Beer et al. ( | 28 | PC | DV | *** | – | – | – | – | – | – | C | – | – | – | – | – | – |
| Hastings and Brown ( | 26 | HMR | DV | n.s. | – | – | – | – | – | – | – | – | ** | – | – | – | – |
Studies are presented in order of size (descending). For each study, the dependent variable (DV) is denoted and other variable are treated as independent variables (IV). Their contribution to final model is denoted by its significance (n.s. non-significant; †p < .1; *p < .05; **p < .01; ***p < .001; ****p < .0001). Variables of interest not included as IV in individual studies are denoted with –. Types of analysis are coded as: MR multiple regression (variables entered simultaneously or type not specified); SMR stepwise multiple regression; HMR hierarchical multiple regression; PC partial correlation; SPC semi-partial correlation; LMR logistic multiple regression; C controlled variable
Longitudinal analyses
| Study | Sample size ( | Mean interval (months) | Retention (%) | Child scale (subscale) | Parent scale (subscale) | Type of analysis (statistic) | Child-to-parent prediction | Parent-to-child prediction | Other variables in model | |
|---|---|---|---|---|---|---|---|---|---|---|
| Zaidman-Zait et al. ( | 184 | 4 | 12 | NR | CBCL 1.5-5 (ext.) | PSI-SF (PD) | Cross time correlation | * | * | – |
| Baker et al. ( | 149 | 2 | 36 | 89.2 | SIB-R | CES-D | Cross time correlation | * | * | Mother–child relationship quality; family adaptability |
| Totsika et al. ( | 132 | 2 | 24 | NR | SDQ | K6 | Cross-time correlation | n.s. | ** | Family deprivation |
| Benson ( | 113 | 3a | 24 | 84.0 | NCBRF | Own MHP scale (change over time) | Multilevel modelling | * | - | Child age; child pro-social behavior; parent use of coping mechanisms |
| Peters-Scheffer et al. ( | 104 | 3 | 12 | NR | CBCL 1.5-5 | Dutch PSI-SF | Cross time correlation | ** | ** | – |
| Bader et al. (2014) | 84 | 2 | 25 | 75.7 | CBCL (ext.) | PSI-SF (PD) | Cross time correlation | – | n.s. | – |
| Simonoff et al. ( | 81 | 2 | 48 | 47.4 | SDQ | GHQ-30 | Cross time correlation | – | n.s. | – |
| Osborne and Reed ( | 72 | 2 | 9.5 | 100 | SDQ & DBC | PSI | ANCOVA | n.s. | * | Child ASD severity, cognitive ability; adaptive functioning |
| Osborne and Reed ( | 65 | 2 | 9.5 | 100 | CPRS (oppos.) | QRS-F | ANCOVA | n.s. | ** | Child ASD severity; cognitive ability; adaptive functioning |
| Hastings et al. ( | 60 | 2 | 33 | 33 | SDQ | HADS | MR controlling for DV T1 scores | – | n.s. | Sibling SDQ; sibling prosocial behavior |
| Lecavalier et al. ( | 50 | 2 | 12 | NRb | NCBRF | PSI-SF | HMR controlling for DV T1 scores | * | **** | – |
| Reed et al. ( | 32 | 2 | 9.5 | 100 | DBC-P | QRS-F | Cross time correlation | – | † | – |
NR not reported; SEM structural equation modelling; ANCOVA analysis of covariance; MR multiple regression; HMR hierarchical multiple regression; DV dependent variable
n.s. non-significant; †p < .1; *p < .05; **p < .01; ***p < .001; ****p < .0001
aAccelerated longitudinal design
bFifty (19.8%) out of 253 Time 1 participants provided data at Time 2, but it is unclear what proportion of the initial sample was eligible for/contacted at Time 2
cIn the model, the path from Time 1 PS to Time 2 EBP was not significant; however the path from Time 3 PS to Time 4 EBP was significant (p < .01)